Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: DrugBank:EXPT03052 (
THF
)
8,150
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Reaction of the complex [Rh(coe)2(solv)n]
BF4
(coe=cyclooctene) with the phosphane 1-di-tert-butylphosphinomethyl-2,4,6-trimethylbenzene (1) results in selective C-H bond activation, yielding the spectroscopically characterized solvento complexes [(solv)nRhH(CH2C6H2(CH3)2[CH2P(tBu)2]]]
BF4
(solv = acetone, 2a;
THF
, 2b; methanol, 2c). The stability of these complexes is solvent dependent, alcohols providing significant stabilization. Although cis-alkylrhodium hydride complexes containing labile ligands are generally unstable, 2a-c are stable at room temperature. Complex [ (acetone)(ketol)RhH[CH2C6H2(CH3)2[CH2P(t-Bu)2]]]
BF4
(2d, ketol 4-hydroxy-4-methyl-2-pentanone, the product of acetone aldol condensation), crystallized from a solution of 2a in acetone and was structurally characterized. Unusual solvent- and temperature-dependent selectivity in reversible C-H bond elimination of these complexes, most probably controlled by a special mode of strong agostic interactions, is observed by spin saturation transfer experiments.
...
PMID:Solvent-stabilized alkylrhodium(III) hydride complexes: a special mode of reversible C-H bond elimination involving an agostic intermediate 1100 7
The synthesis of Ru(C2H4)(CO)2(dtbpe) (dtbpe = tBu2PC2H4PtBu2), then green [Ru(CO)2(dtbpe)]n is described. In solution, n = 1, while in the solid state, n = 2; the dimer has two carbonyl bridges. DFTPW91, MP2, and CCSD(T) calculations show that the potential energy surface for bending one carbonyl out of the RuP2C(O) plane is essentially flat. Ru(CO)2(dtbpe) reacts rapidly in benzene solution to oxidatively add the H-E bond of H2, HCl, HCCR (R = H, Ph), [HOEt2]
BF4
, and HSiEt3. The H-C bond of C6HF5 oxidatively adds at 80 degrees C. CO adds, as does the C=C bond of H2C=CHX (X = H, F, Me). The following do not add: N2,
THF
, acetone, H3COH, and H2O.
...
PMID:Unsaturated Ru(0) species with a constrained bis-phosphine ligand: [Ru(CO)2(tBu2PCH2CH2PtBu2)]2. Comparison to [Ru(CO)2(PtBu2Me)2]. 1119 47
The complexes [(DMA)Cu(PPh3)2](
BF4
) (1) (DMA = 1,3-dimethylalloxazine), [(DMA)Ru(bpy)2](PF6)2 (2), and (DMA)WO2Cl2 (3) were obtained as O4-N5-chelated species, as evident from an X-ray crystal structure analysis for 3 and from spectroscopy (NMR, IR, and UV-vis spectroelectrochemistry) for 1 and 2. The tungsten(VI) center in 3 has its oxide ligands in a cis/equatorial position and the chloride ligands in a trans/axial position; it also exhibits a relatively short bond to O4 (2.232(3) A) and a very long bond to N5 (2.462(3) A). Comparison with the new structurally characterized compound (BIK)WO2Cl2 (4) (BIK = bis(1-methylimidazol-2-yl)ketone), which has W-N bonds of about 2.30 A, confirms the unusual length of the W-N bond in 3, probably caused by repulsion between one of the oxo ligands and the peri-hydrogen atom (H6) of DMA. One-electron reduction of the complexes occurs reversibly at room temperature in
THF
(1, 2) or at 198 K in CH2Cl2 (3). EPR spectroscopy reveals that this process is ligand-centered for 1 and 2 but metal-centered for 3. Density functional methods and ab initio methodology are used to illustrate the correspondence in spin distribution between the radical anion pi systems of alloxazine and isoalloxazine ("flavosemiquinone").
...
PMID:Metal vs ligand reduction in complexes of 1,3-dimethylalloxazine (DMA) with copper(I), ruthenium(II), and tungsten(VI). Crystal structures of (DMA)WO2Cl2 and (bis(1-methylimidazol-2-yl)ketone)WO2Cl2. 1119 60
Seven compounds having in common a Cr3(dpa)4(3+) core (dpa = di(2-pyridyl)amide ion) have been prepared and all shown to have an unsymmetrical chain of three Cr atoms. This chain can be described as a pair of quadruply bonded Cr(II) atoms to which a Cr(III) atom is attached. No symmetrical chain has been found, contrary to a previous preliminary report. The seven compounds have been well characterized crystallographically, and their short and long Cr to Cr distances (A, in parentheses) are: 1 [Cr3(dpa)4Cl2]Cl.2CH2Cl2.
THF
(2.12, 2.47), 2 [Cr3(dpa)4Cl2]AlCl4.CH2Cl2 (2.011, 2.555), 3 [Cr3(dpa)4Cl2]FeCl4.CH2Cl2 (2.009, 2.562), 4 [Cr3(dpa)4Cl2]I3.
THF
.2H2O (2.08, 2.49), 5 [Cr3(dpa)4Cl2]PF6.2CH2Cl2 (2.08, 2.48), 6 [Cr3(dpa)4(
BF4
)F]
BF4
.2CH2Cl2 (1.900, 2.595), 7 [Cr3(dpa)4ClF]
BF4
.CH2Cl2.C6H14 (2.039, 2.507). Magnetic susceptibility measurements on 1 and 2 reveal mueff = 3.85 +/- 0.05 muB from 10 to 300 K.
...
PMID:Linear trichromium complexes with direct Cr to Cr contacts. 2. Compounds with Cr3(dipyridylamide)4(3+) cores. 1127 72
The reaction of Fe(II)(C5Me5)(C5H5), FeCpCp, with percyano acceptors, A [A = C4(CN)6 (hexacyanobutadiene), TCNQF4 (perfluoro-7,7,8,8-tetracyano-p-quinodimethane), and DDQ (2,3-dichloro-5,6-dicyanobenzoquinone)], results in formation of 1:1 charge-transfer salts of [Fe(III)CpCp]*]*+[A]*- composition. With A = TCNQ (7,7,8,8-tetracyano-p-quinodimethane) a 1:2 electron-transfer salt with FeCpCp forms. With A = TCNE (tetracyanoethylene) a pair of 1:1 salts as well as a pair of 2:3 salts of [FeCpCp]2[TCNE]3.S (S = CH2Cl2,
THF
) have been isolated and characterized by single-crystal X-ray diffraction. [FeCpCp][TCNE] consists of parallel 1-D.D(*+)A(*-)D(*+)A(*-)D(*+)A(*-). chains, while [FeCpCp][TCNE].MeCN has a herringbone array of D(*+)A2(2-)D(*+) dimers separated by solvent molecules. Although each [TCNE](-) is disordered, the diamagnetic [TCNE]2(2-) dimer is structurally different from those observed earlier with an intradimer separation of 2.79 A. The [TCNE](-) in the 2:3 [FeCpCp]2[TCNE]3.S exists as an eclipsed diamagnetic [TCNE]2(2-) dimer with an intradimer ethylene C.C separation of 2.833 and 2.903 A for the CH2Cl2- and
THF
-containing materials, respectively. The bond distances and angles for all the cations are essentially equivalent, and the distances are essentially equivalent to those previously reported for [FeCp2](*+) and [FeCp2](*+) cations. The average Fe-C5H5-ring and Fe-C5Me5-ring centroid distances are 1.71 and 1.69 A, respectively, which are 0.05 A longer than reported for Fe(II)CpCp. The one-electron reduction potential for Fe(II)CpCp is 0.11 V (vs SCE). The 5 K EPR of [FeCpCp](*+)[
BF4
](-) exhibits an axially symmetric powder pattern with g(parallel) = 4.36 and g(perpendicular) = 1.24, and the EPR parameters are essentially identical to those reported for ferrocenium and decamethylferrocenium. The high-temperature magnetic susceptibility for polycrystalline samples of these complexes can be fit by the Curie-Weiss law, chi = C/(T - theta), with low theta values and mu(eff) values from 2.08 to 3.43 mu(B), suggesting that the polycrystalline samples measured had varying degrees of orientation. [FeCpCp][TCNE] exhibits the highest effective moment of 3.43 mu(B)/Fe and weak ferromagnetic coupling, as evidenced from the theta of 3.3 K; however, unexpectedly, it does not magnetically order above 2 K. The formation of the four phases comprising FeCpCp and TCNE emphasizes the diversity of materials that may form and the present inability to predict neither solid-state compositions nor structure types.
...
PMID:Electron-transfer salts of 1,2,3,4,5-pentamethylferrocene, Fe(II)(C5Me5)(C5H5). Structure and magnetic properties of two 1:1 and two 2:3 Fe(C5Me5)(C5H5) electron-transfer salts of tetracyanoethylene. 1130 50
The title compounds are accessed by sequences starting with racemic and enantiomerically pure [(eta5-C5H5)Re(NO)(PPh3)(CH3)]. Reactions with chlorobenzene/HBF4, PPh2H, and tBuOK give the phosphido complex [(eta5-C5H5)Re(NO)(PPh3)(PPh2)] (3). Reactions with Ph3C+
BF4
-, PPh2H, and tBuOK give the methylene homologue [(eta5-C5H5)Re(NO)(PPh3)(CH2PPh2)] (9). Treatment of 3 or 9 with nBuLi or tBuLi and then PPh3Cl gives the diphosphido systems [(eta5-C5H4PPh2)Re(NO)(PPh3)((CH2)nPPh2)] (n = 0/1, 5/11). Reactions of 5 and 11 with [Rh(NBD)Cl]2/AgPF6 (NBD = norbornadiene) give the rhenium/rhodium chelate complexes [(eta5-C5H4PPh2)Re(NO)(PPh3)((mu-CH2)nPPh2)Rh(NBD)]+ PF6- (n = 0/1, 6+/12+ PF6-; 30-32% overall from commercial Re2(CO)10). The crystal structures of 6+ PF6- and 12+ PF6- are compared to those of 3 and 9, and other rhodium complexes of chelating bis(diphenylphosphines). The chiral pockets defined by the PPh2 groups show unusual features. Four alkenes of the type (Z)-RCH=C(NHCOCH3)CO2R' are treated with H2 (1 atm) and (R)-6+ PF6- or (S)-12+ PF6- (0.5 mol%) in
THF
at room temperature. Protected amino acids are obtained in 70-98% yields and 93-82% ee [(R)-6- PF6-] or 72-60% ee [(S)-12+ PF6-]. Pressure and temperature effects are defined, and turnover numbers of > 1600 are realized.
...
PMID:A new family of chelating diphosphines with a transition metal stereocenter in the backbone: novel applications of "chiral-at-rhenium" complexes in rhodium-catalyzed enantioselective alkene hydrogenations. 1140 81
The tropylium salt (2-hydroxy-3,5-dimethylphenyl)cycloheptatrienylium tetrafluoroborate (3) has been synthesized in three steps from THP-protected 2,4-dimethylphenol and tropylium tetrafluoroborate, (C(7)H(7))BF(4). In CH(2)Cl(2) solution, the unexpected formation of tricyclic 2,4-dimethylbenzo[b]cyclohepta[d]furanylium tetrafluoroborate (5) has been observed, which must have formed from 3 by loss of H(2). 5 was characterized by an X-ray crystal structure determination and could independently be synthesized by treatment of 3 with NaHCO(3) to give 2,4-dimethylbenzo[b]cyclohepta[d]furan (4) followed by acidification with HBF(4).Et(2)O. The arene transfer reaction of 3 with [(eta-p-xylene)Mo(CO)(3)] furnished the cycloheptatrienyl complex [(HOC(6)H(2)Me(2)-eta(7)-C(7)H(6))Mo(CO)(3)]BF(4) (6), which could be converted into the chiral chelate complexes [(OC6H2Me2-eta7-C7H6)Mo(CO)(PR3)](9a, R = Ph; 9b, R = c-C(6)H(11); 9c, i-Pr) by subsequent treatment with NaI, PR(3), and NaH. The linked cycloheptatienyl-phenolate ligand in 9a could be protonated at the coordinated oxygen atom employing HBF(4).Et(2)O to yield [(HOC6H2Me2-eta7-C7H6)Mo(CO)(PPh3)]-
BF4
(10). In 10, the appended phenol group is coordinated in a hemilabile fashion, which allowed the introduction of 2,6-dimethylphenyl isocyanide and CO and formation of complexes [(HOC(6)H(2)Me(2)-eta(7)-C(7)H(6))Mo(CO)(PPh(3))L]BF(4) (11, L = XyNC; 12, L = CO). On thermal reaction of [(HOC(6)H(2)Me(2)-eta(7)-C(7)H(6))Mo(CO)(2)I] (7) with dppe, the addition of the diphosphine was observed together with the simultaneous formation of the molydenum-oxygen bond to yield [(OC6H2Me2-eta3-C7H6)Mo(CO)2(dppe)] (13), in which the cycloheptatrienyl ring has reduced its hapticity from seven to three. The pseudooctahedral complex 13 exhibits an interesting fluxional behavior in solution, which has been studied by means of variable-temperature (31)P and (1)H NMR spectroscopy. A eta(3) --> eta(7) hapticity reversion could be achieved by UV irradiation of a solution of 13 in
THF
to give the electron-rich complex [(OC6H2Me2-eta7-C7H6)Mo(dppe)] (14). 14 was readily oxidized with ferrocenium hexafluorophosphate, and the resulting paramagnetic monocationic complex 15 has been studied by means of ESR spectroscopy and X-ray diffraction. In addition, the X-ray crystal structures of complexes 9a, 10.2CH(2)Cl(2), 12, and 13 are reported.
...
PMID:Molybdenum complexes with linked cycloheptatrienyl-phenolate ligands. 1178 43
The preparation of an 1,3-alternate calix[4]arene phosphorus ligand, 25,27-bis(2-(diphenylphosphino)ethoxy)-26,28-bis(1-propyloxy)calix[4]arene (3), is presented. Ligand 3 is obtained in three steps in 64% overall yield. Reaction of 3 with [Rh(cot)2]
BF4
produced the encapsulated rhodium complex [Rh[(P,P)-diphen-calix[4]arene]]
BF4
(4). As revealed by a single-crystal X-ray diffraction study, the rhodium center has a bent coordination environment with a P-Rh-P angle of 135.66(3) degrees. Palladation of 3 employing [Pd(MeCN)4](
BF4
)2 yielded the chelate palladium complex 7 in which the palladium center has a slightly bent configuration. Treatment of the ligand with Pd(cod)Cl2 and [Pd(eta3-C4H7)(
THF
)2]
BF4
leads to the isolation of the monometallic complex. Full characterization includes X-ray structural studies of compounds 3, 4, and 6.
...
PMID:Metallic macrocycle with a 1,3-alternate calix[4]arene phosphorus ligand. 1510 78
The complexes, CpRu(CO)2(
BF4
) and [CpFe(CO)2(eta2-2-methylpropene)][
BF4
], react with dibenzothiophene (DBT) and 4,6-dimethyldibenzothiophene (4,6-Me2DBT) to give [CpRu(CO)2(DBT)][
BF4
] and [CpFe(CO)2(4,6-Me2DBT)][
BF4
], whose structures were established by X-ray diffraction studies. The same types of products are obtained when dibenzothiophenes react with CpRu(CO)2(
BF4
) and [CpFe(CO)2(
THF
)][
BF4
] that are adsorbed on the mesoporous silica SBA-15. DRIFT and XPS studies indicate that CpRu(CO)2(
BF4
) and [CpRu(CO)2(DBT)][
BF4
] are adsorbed on the SBA-15 by hydrogen-bonding of the
BF4
- anions to surface Si-O-H groups. CpRu(CO)2(
BF4
)/SBA-15 removes 99% of the DBT in a 45% toluene/55% hexanes simulated petroleum feedstock. This solid phase extractant is less successful for sterically-hindered 4,6-Me2DBT, as only 72% of it is removed. The results show that CpRu(CO)2(
BF4
) can be immobilized by adsorption on mesoporous silica and that it reacts with dibenzothiophenes in the adsorbed form, CpRu(CO)2(
BF4
)/SBA-15, in much the same way that it reacts in solution.
...
PMID:CpRu(CO)2(BF4) and [CpFe(CO)2(THF)]+ on mesoporous silica as adsorbents for the removal of dibenzothiophenes from hydrocarbon solutions. 1525
Iridium complexes of DMA-imine [2,6-dimethylphenyl-1'-methyl-2'-methoxyethylimine, 1 a) and (R)-DMA-amine [(1'R)-2,6-dimethylphenyl-1'-methyl-2'-methoxyethylamine, 2 a] that are relevant to the catalytic imine hydrogenation step of the Syngenta (S)-Metolachlor process were synthesized: metathetical exchange of [Ir2Cl2(cod)2] (cod=1,5-cyclooctadiene) with [Ag(1 a)2]
BF4
and [Ag((R)-2 a)2]
BF4
afforded [Ir(cod)(kappa2- -1 a)]
BF4
(11) and [Ir(cod)(kappa2-(R)-2 a)]
BF4
((R)-19)), respectively. These complexes were then used in stopped-flow experiments to study the displacement of amine 2 a from complex 19 by imine 1 a to form the imine complex 11, thus modeling the product/substrate exchange step in the catalytic cycle. The data suggest a two-step associative mechanism characterized by k1=(2.6+/-0.3) x 10(2) M(-1) s(-1) and k2=(4.3+/-0.6) x 10(-2) s(-1) with the respective activation energies EA1=(7.5+/-0.6) kJ mol(-1) and EA2=(37+/-3) kJ mol(-1). Furthermore, complex 11 reacted with H2O to afford the hydrolysis product [Ir(cod)(eta(6-)-2,6-dimethylaniline)]
BF4
(12), and with I2 to liberate quantitatively the DMA-iminium salt 14. On the other hand, the chiral amine complex (R)-19 formed the optically inactive eta6-bound compound [Ir(cod)(eta6-rac-2 a)]
BF4
(rac-18) upon dissolution in
THF
at room temperature, presumably via intramolecular C-H activation. This racemization was found to be a two-step event with k'1=9.0 x 10(-4) s(-1) and k2=2.89 x 10(-5) s(-1), featuring an optically active intermediate prior to sp3 C-H activation. Compounds 11, 12, rac-18, and (R)-19 were structurally characterized by single-crystal X-ray analyses.
...
PMID:Iridium-imine and -amine complexes relevant to the (S)-metolachlor process: structures, exchange kinetics, and C-H activation by Iri causing racemization. 1537 34
1
2
3
4
5
Next >>